Pharma Cos., FDA Debate 'Same Drug' In Orphan Drug Case

By Ali Sullivan · May 10, 2024, 9:26 PM EDT

Two pharmaceutical companies and the U.S. Food and Drug Administration faced off in D.C. federal court Friday over allegations that the federal agency wrongly approved a treatment that rivals Jazz Pharma's...

To view the full article, register now.